Eur J Immunol. 2000 Apr;30(4):1060-8. Unique Identifier : AIDSLINE
Considerable evidence suggests that the ERK pathway is required for
positive but not negative thymocyte selection. Here, we report that ERK
is highly activated in double-positive (DP) thymocytes expressing an MHC
class I-restricted TCR (P14) in response to negatively selecting
conditions, whereas ligands that trigger positive selection induced
weaker ERK activation. Biochemical evidence also shows that death by
neglect is associated with a further reduction in ERK activation. These
findings are consistent with the affinity / avidity model of thymocyte
selection. To further examine the role of ERK in negative selection we
used the MEK-1 inhitibor, PD98059, a specific pharmacological inhibitor
of the ERK pathway. Biochemical data demonstrated a reduction of ERK
activity by PD98059 in the presence of the negatively selecting ligand.
Analysis of P14 TCR-transgenic fetal thymic lobes cultured with PD98059
under negatively selecting conditions showed impaired clonal deletion of
DP thymocytes and a concomitant increase in positive selection of
functional mature, TCR(hi) transgenic T cells. This demonstrates that
altering ERK activity switched negative to positive selection. Contrary
to previous reports that show an exclusive role for ERK signaling in
positive selection, our data demonstrate that negative selection is also
sensitive to the degree of ERK activation.
JOURNAL ARTICLE Animal Cell Differentiation/DRUG EFFECTS Cell
Division/DRUG EFFECTS Cell Lineage/DRUG EFFECTS Cell Survival/DRUG
EFFECTS CD8-Positive T-Lymphocytes/DRUG EFFECTS/IMMUNOLOGY DNA-Binding
Proteins/GENETICS/IMMUNOLOGY Enzyme Activation/DRUG EFFECTS
Flavones/PHARMACOLOGY H-2 Antigens/GENETICS/IMMUNOLOGY Ligands Mice
Mice, Transgenic Mitogen-Activated Protein Kinase Kinases/ANTAGONISTS &
INHIB/ METABOLISM Mitogen-Activated Protein Kinases/ANTAGONISTS &
INHIB/*METABOLISM MAP Kinase Signaling System/DRUG EFFECTS Organ
Culture Peptides/PHARMACOLOGY Protein-Serine-Threonine
Kinases/ANTAGONISTS & INHIB/METABOLISM Receptors, Antigen,
T-Cell/IMMUNOLOGY Support, Non-U.S. Gov't
T-Lymphocytes/*ENZYMOLOGY/*IMMUNOLOGY Thymus Gland/CYTOLOGY/DRUG
EFFECTS/IMMUNOLOGY